Skip to main content
OpenTrials

Clinical trial condition

Neoplasms, Connective and Soft Tissue

Explore clinical trials studying Neoplasms, Connective and Soft Tissue. Study availability and eligibility vary by location and protocol.

2,726 public trials 585 recruiting studies
Refine in advanced search Browse all conditions

Neoplasms, Connective and Soft Tissue trial results

Active, Not Recruiting

Study Evaluating the Safety and Efficacy of MEDI5752 in Combination With Stereotactic Radiotherapy in Patients With Metastatic Sarcoma

NCT05821231

Conditions
Neoplasms, Neoplasms by Histologic Type, Neoplasms, Connective and Soft Tissue, +2 more
Locations
  • Institut Bergonié Bordeaux, France
  • Centre Oscar Lambret Lille, France
  • Centre Leon Berard Lyon, France
  • Institut Regional Du Cancer de Montpellier Montpellier, France
View Trial Details
Active, Not Recruiting

A Study to Investigate Efficacy & Safety of Intratumoral INT230-6 Compared to US Standard of Care in Adults With Soft Tissue Sarcomas (INVINCIBLE-3)

NCT06263231

Conditions
Neoplasms, Neoplasms by Histologic Type, Neoplasms, Connective and Soft Tissue, +2 more
Locations
  • USC/Norris Comprehensive Cancer Center Los Angeles, California, United States
  • Sarcoma Oncology Center Santa Monica, California, United States
  • University of California Los Angeles (UCLA) - Santa Monica Cancer Care Santa Monica, California, United States
  • Yale School of Medicine - Smilow Cancer Hospital - Yale - New Haven Hospital Location New Haven, Connecticut, United States
View all 17 locations
View Trial Details
Active, Not Recruiting

Combined Chemotherapy With or Without Zoledronic Acid for Patients With Osteosarcoma

NCT00470223

Conditions
Neoplasms, Neoplasms by Histologic Type, Neoplasms, Bone Tissue, +4 more
Locations
  • Centre Paul Papin Angers, France
  • Institut Gustave Roussy Angers, France
  • Centre Hospitalier Regional de Besancon - Hopital Jean Minjoz Besançon, France
  • CHR de Besancon - Hopital Saint-Jacques Besançon, France
View all 37 locations
View Trial Details
Active, Not Recruiting

Safety, PK and Efficacy of ONC-392 in Monotherapy and in Combination of Anti-PD-1 in Advanced Solid Tumors and NSCLC

NCT04140526

Conditions
Adenocarcinoma, Adenoid Cystic Carcinoma, Adnexal Diseases, +94 more
Locations
  • Highlands Oncology Group Springdale, Arkansas, United States
  • University of California at Davis Davis, California, United States
  • The Oncology Institute of Hope and Innovation Downey, California, United States
  • City of Hope Cancer Center Duarte, California, United States
View all 37 locations
View Trial Details

Related conditions